(HealthDay)—Colon cancer patients with elevated preoperative carcinoembryonic antigen (CEA) levels that normalize after resection are not at increased risk for poor prognosis, according to a study ...
Conventional tumor markers may serve as adjuncts in non-small cell lung cancer (NSCLC) management. In a new study, researchers Scott Strum, Mark Vincent, Meghan Gipson, Eric McArthur, and Daniel ...
Using RECIST criteria for tumor progression and disease response, the mean change in CEA for patients with progression was an increase in 19 ng/mL, compared to a change of –7.3 ng/mL in those with ...
A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...
Helicobacter pylori infection and the risk of colorectal cancer: A meta-analysis of epidemiologic evidence. Background: Carcinoembryonic antigen (CEA) is a widely used tumor marker for surveillance in ...
Epidemiology of rectal and small intestinal carcinoids: Two distinct tumors? Background: Serum carcinoembryonic antigen (CEA) level can be used as a sensitive marker of recurrence in the follow up of ...
A team of scientists from KTH Royal Institute of Technology and Karolinska Institutet has reported the development and characterization of a new class of small non-immunoglobulin affibody proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results